Biodistribution and Dosimetry of Intraventricularly Administered (124)I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors

Radiation dose estimations are key for optimizing therapies. We studied the role of (124)I-omburtamab (8H9) given intraventricularly in assessing the distribution and radiation doses before (131)I-omburtamab therapy in patients with metastatic leptomeningeal disease and compared it with the estimate...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Nucl Med
Auteurs principaux: Pandit-Taskar, Neeta, Zanzonico, Pat B., Kramer, Kim, Grkovski, Milan, Fung, Edward K., Shi, Weiji, Zhang, Zhigang, Lyashchenko, Serge K., Fung, Alex M., Pentlow, Keith S., Carrasquillo, Jorge A., Lewis, Jason S., Larson, Steven M., Cheung, Nai-Kong V., Humm, John L.
Format: Artigo
Langue:Inglês
Publié: Society of Nuclear Medicine 2019
Sujets:
Radiobiology/Dosimetry
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894373/
https://ncbi.nlm.nih.gov/pubmed/31405921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.219576
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires